A Canadian Biotechnology company dedicated to the domestic manufacture of clinical-grade MDMA in service to the scientific research community

Our Mission

 

PharmAla Biotech was formed by a devoted team of biomanufacturing, regulatory and financial professionals, driven by the belief that MDMA shows incredible clinical promise as a treatment for numerous disorders. We believe that the only way to advance the scientific research which will eventually allow for the formal approval of MDMA as a medicine is to ensure that researchers have a steady and accessibly supply of clinical grade Active Pharmaceutical Ingredient (API).

Our Approach

PharmAla works with established, best-in-class laboratories across Canada to develop novel processes for manufacturing of MDMA and other MDXX substances. We hold ourselves to the highest standards of compliance and rigour in our manufacturing processes.

i

Our Research

PharmAla Biotech is researching novel formulation methods, delivery pathways, and manufacturing techniques to ensure that the MDMA developed by the company can be delivered by researchers and clinicians with a maximum of safety, while reducing cost.

Company News

 

Coming Soon

Sign Up

Register to our email list to recieve the latest Company development’s sent directly to your inbox.

1 + 15 =

Register to our email list to recieve the latest Company development’s sent directly to your inbox.

1 + 4 =